The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
SI-B003 (PD-1/CTLA-4) in patients with advanced solid tumors: A phase I study.
 
Yakun Wang
No Relationships to Disclose
 
Yongsheng Li
No Relationships to Disclose
 
Jiyan Liu
No Relationships to Disclose
 
Su-xia Luo
Consulting or Advisory Role - KYM Biosciences
 
Qi Li
No Relationships to Disclose
 
Wen Zou
Employment - Baili Biopharmaceutical
 
Zhaoxiang Wang
Employment - Baili Biopharmaceutical
 
Yujia Peng
Employment - Baili Biopharmaceutical
 
Sa Xiao
Employment - Baili Biopharmaceutical
Stock and Other Ownership Interests - Baili Biopharmaceutical
 
Hongwei Wang
No Relationships to Disclose
 
Hai Zhu
Employment - Baili Biopharmaceutical (I); Systimmune; Systimmune (I)
Leadership - Baili Biopharmaceutical (I); Systimmune (I)
Stock and Other Ownership Interests - Baili Biopharmaceutical (I); Systimmune; Systimmune (I)
 
Martin Sebastian Olivo
Employment - Gilead Sciences; Protara Therapeutics; Systimmune
Leadership - Protara Therapeutics; Systimmune
Stock and Other Ownership Interests - Gilead Sciences; Protara Therapeutics; SystImmune
(OPTIONAL) Uncompensated Relationships - Phoenix Molecular Designs
 
Yi Zhu
Employment - Baili Biopharmaceutical; SystImmune; Systimmune (I)
Leadership - Baili Biopharmaceutical; SystImmune
Stock and Other Ownership Interests - Baili Biopharmaceutical; SystImmune; SystImmune (I)
 
Lin Shen
Consulting or Advisory Role - AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squib; Daiichi Sankyo; Harbour BioMed; Merck; Mingji biopharmaceutical; MSD; Roche; Sanofi
Research Funding - Baiji Shenzhou (Beijing) Biotechnology (Inst); Beijing Xiantong Biomedical Technology (Inst); CANbridge Pharmaceuticals (Inst); Jacobio (Inst); Nanjing Yaojieankang Biotechnology (Inst); QiLu Pharmaceutical (Inst); Zaiding Pharmaceutical (Inst)